The latest board meeting for Amicus Therapeutics Inc took place on 09 Sep 2025, for the purpose of Morgan Stanley 23rd Annual Global Healthcare Conference 2025See details
Amicus Therapeutics Inc has a share price target of US$ 16, revenue growth forecast of 18.6%, and profit growth estimate of 72.7% for FY25, based on top 12 analyst calls.